Loading organizations...
Macrosynergy operates as a global macro fund, employing systematic strategies to capitalize on worldwide economic trends. Its investment approach involves comprehensive analysis of geopolitical and financial shifts, aiming to generate alpha through diverse asset classes across global markets. The firm leverages its analytical framework to identify and exploit dislocations in global markets, offering a disciplined approach to macroeconomic investing.
The firm was established in 2009 by co-founders Robert Enserro and Nikos Makris. Their shared insight into the opportunities presented by a rigorous, data-driven approach to global macroeconomic analysis led to the creation of their flagship trading fund. Enserro and Makris brought substantial expertise in quantitative methods and market dynamics to their venture, forming the foundational principles of the company's investment philosophy.
Macrosynergy serves sophisticated institutional and qualified individual investors seeking exposure to actively managed global macro strategies. The company's vision centers on delivering consistent risk-adjusted returns by adeptly navigating complex global economic cycles and exploiting market inefficiencies through their systematic framework, anticipating future market movements and adapting to evolving market conditions.
Macro Capital Investments has 1 tracked investment across 1 company. The latest tracked deal is $18.0M Series D in Greenlight Biosciences in September 2017.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 14, 2017 | Greenlight Biosciences | $18.0M Series D | Eric O'Brien | Dave Furneaux, Lewis & Clark Ventures, Ganesh Kishore, S2G Ventures, Syngenta Ventures |